Chicago, ILNCT01280825Now EnrollingIRB Ready

Patients Undergoing Routine Health Care Clinical Trial in Chicago, IL

Access cutting-edge patients undergoing routine health care treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.

Sponsored by University of Chicago

Quick Self-Assessment

See if you qualify for this Chicago location

Preparing your pre-screening questions…

Expert Care in Chicago

Access patients undergoing routine health care specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related patients undergoing routine health care treatment provided free

Apply for This Chicago Location

Check if you qualify for this patients undergoing routine health care clinical trial in Chicago, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago site if eligible
  4. 4Begin participation

About This Patients Undergoing Routine Health Care Study in Chicago

The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differences in genes that may suggest greater risk of side effects or chance of increased benefit from certain medications. The results will be made available to the patient's treating physician and the researchers will track whether or not this information is used in routine health care.

Sponsor: University of Chicago

Who Can Participate

Inclusion Criteria

Receiving ongoing, out-patient care at the University of Chicago Medical Center under the routine care of a physician participating in this trial
Life expectancy of at least 3 years
Must be 18 years or older
Must be taking at least 1 (but not more than 6) prescription medications at the time of enrollment OR be 65 years or older OR be reasonably expected to require the use of a prescription medication within the next 5 years
Patients with certain diseases, or likely to receive or be receiving certain drugs, will be targeted particularly for enrollment in order to enrich the study for patients likely to have pharmacogenetically relevant interactions, including, but not limited to:
Patients requiring specialized cardiology care
Patients with inflammatory bowel diseases
Patients with systemic autoimmune or inflammatory diseases
Patients requiring long-term oral anticoagulation
Patients with hepatitis C
Patients with non-metastatic cancer

Exclusion Criteria

Patients with acute or chronic disease which could be reasonably expected to result in the patient's death within the next 3 years.
Patients who have undergone, or are being actively considered for, liver or kidney transplantation.
Inability to understand and give informed consent to participate.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT01280825) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Patients Undergoing Routine Health Care Treatment Options in Chicago, IL

If you're searching for patients undergoing routine health care treatment options in Chicago, IL, this clinical trial (NCT01280825) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced patients undergoing routine health care specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all patients undergoing routine health care clinical trials near you to find additional studies recruiting in your area.

More UTI Trials in Chicago, IL

See all uti clinical trials recruiting in Chicago — not just this study.

Browse UTI Trials in Chicago →

Browse More Trials by Condition

UTI TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Chicago?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago, IL